Aesthetic surgery journal. Open forum最新文献

{"title":"Affordable Indocyanine Green Imaging: A Handmade Low-Cost Camera for Lymphatic Surgery Application.","authors":"Sina Heymans, Maximilian Mahrhofer, Magdalena Lewicki, Bernadette Muth, Sven Lamprecht, Thomas Schoeller, Laurenz Weitgasser","doi":"10.1093/asjof/ojag042","DOIUrl":"https://doi.org/10.1093/asjof/ojag042","url":null,"abstract":"<p><strong>Background: </strong>Indocyanine green (ICG) has become an essential tool in lymphatic and vascular surgery because of its ability to provide real-time, near-infrared fluorescence imaging of both lymphatic structures and blood vessels. This technology enhances intraoperative decision making by allowing the surgeon to evaluate tissue perfusion, visualize lymphatic and blood channels, and confirm the patency of vascular anastomosis. Owing to these advantages, its use has become increasingly popular in lymphaticovenous anastomosis procedures and flap-based reconstructions. However, commercially available ICG imaging systems are associated with high costs, which limits accessibility to this technology.</p><p><strong>Objectives: </strong>To address this limitation, the authors of this study developed a cost-effective camera system for real-time ICG angiography.</p><p><strong>Methods: </strong>In this paper, the authors describe the technical components and assembly process of their camera system. They also share their initial intraoperative experiences with this device in a series of lymphatic surgeries.</p><p><strong>Results: </strong>Early results demonstrate that the camera provides clear imaging of lymphatic channels and blood vessels at a fraction of the cost of standard commercial systems. Its use is reliable and beneficial for intraoperative visualization.</p><p><strong>Conclusions: </strong>The budget-friendly, handmade ICG camera may deliver reliable intraoperative imaging of lymphatic and vascular structures. This approach may broaden the access to ICG technology in resource-limited environments.</p><p><strong>Level of evidence 5 therapeutic: </strong></p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag042"},"PeriodicalIF":1.9,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13098129/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Correction to: Wound Coverage, Adjuvant Treatments, and Surgical Outcomes for Major Keloid Scars: A Systematic Review and Meta-Analysis.","authors":"","doi":"10.1093/asjof/ojag038","DOIUrl":"https://doi.org/10.1093/asjof/ojag038","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1093/asjof/ojae129.].</p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag038"},"PeriodicalIF":1.9,"publicationDate":"2026-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12937587/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147328101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and Efficacy of Surgical Techniques in Treating Lipedema: Systematic Review.","authors":"José Alejandro Acuña Vengoechea, Ricardo Coronel Gagliardi, María Isabel Manzano Martín, Camilo Zuleta Valencia, Benito Madiedo Triana, Sonia Blanco Limia, Cristian Rojas Figueroa, Curro Millán, Patrícia Froes Meyer","doi":"10.1093/asjof/ojag039","DOIUrl":"10.1093/asjof/ojag039","url":null,"abstract":"<p><p>Lipedema is a chronic disorder characterized by abnormal subcutaneous fat accumulation, mainly in women's lower limbs. The aim of the study was to analyze the safety and efficacy of liposuction in treating lipedema. A systematic review was conducted in PubMed, Scopus, and MEDLINE until June 2024 using the terms \"lipedema,\" \"liposuction,\" \"results,\" and \"complications.\" Twenty-five studies were included (<i>n</i> = 2373 patients). Liposuction, mainly using the tumescent infiltration, reduced pain, BMI, and functional limitations, with improvements in mobility and quality of life. Mean aspirated fat volume was 3077 mL per session and 6111 mL per treatment course. Complications were uncommon (hematomas, edema, anemia, DVT, and rare methemoglobinemia). Moreover, improvements were maintained during the follow-up, suggesting that the beneficial results were sustained over time. Although 15 studies reported using tumescent, only 2 fully described the anesthetic fluid composition. Liposuction is a safe and effective treatment for lipedema, but variability in techniques and postoperative care highlights the need for standardized protocols and further research. <b>Level of Evidence</b>: 4 (Therapeutic).</p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag039"},"PeriodicalIF":1.9,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13010320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147516708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Long-Acting Combination Nerve Block in Rhinoplasty to Minimize Postoperative Opioid Use.","authors":"Madison Mai-Lan Cheung, Anil R Shah","doi":"10.1093/asjof/ojag022","DOIUrl":"https://doi.org/10.1093/asjof/ojag022","url":null,"abstract":"<p><p>Minimizing the use of narcotics has been a primary concern in rhinoplasty in order to limit severe side effects and complications associated with opioid use, with addiction being of particular concern. The senior author previously described a bupivacaine nerve block technique in rhinoplasty that significantly reduced postoperative recovery times as well as narcotic, antiemetic, and benzodiazepine use. The aim of this study was to see whether a more potent nerve block composed of bupivacaine with the addition of dexmedetomidine and dexamethasone will result in the patient's avoidance of narcotics following rhinoplasty. A retrospective analysis was conducted on a total of 357 consecutive patients who underwent primary rhinoplasty with a single surgeon. Patients were administered an updated nerve block with a combination of bupivacaine, dexmedetomidine, and dexamethasone. The length of recovery time and use of postoperative medications were collected. In this cohort, 355 of 357 patients avoided postoperative opioids with a 99.4% success rate. No patients experienced side effects from the nerve block. The use of a combination nerve block with bupivacaine, dexmedetomidine, and dexamethasone can lead to successful reduction of postoperative opioid use. Future studies will compare the use of postoperative medications and duration of recovery time between patients who were administered this updated combination nerve block and those who did not receive the combination nerve block. <b>Level of Evidence</b>: 4 (Therapeutic).</p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag022"},"PeriodicalIF":1.9,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12975179/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147438009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Serum Sickness After Cosmetic Botulinum Toxin Type A Injections.","authors":"Danielle DeLuca-Pytell, Kathleen Dass, Gabriella Audia, Elena Busuito","doi":"10.1093/asjof/ojag027","DOIUrl":"10.1093/asjof/ojag027","url":null,"abstract":"<p><p>Botulinum toxin type A (BoNT-A) is widely used in therapeutic and cosmetic settings for neuromuscular and aesthetic indications. Although generally well tolerated, reports of hypersensitivity reactions-ranging from localized erythema to systemic immune syndromes-underscore its immunological complexity. This case report and literature review demonstrates a novel case of serum sickness following cosmetic Botox® (onabotulinumtoxin-A, Allergan Aesthetics, an AbbVie company, Irvine, CA) administration, categorizes hypersensitivity reactions according to the Gell and Coombs classification (Types I-IV), explores the role of complexing proteins and formulation excipients, and highlights emerging clinical concerns. This will underscore the need for greater vigilance in identifying systemic immune responses to BoNT-A especially within the cosmetic medicine industry. <b>Level of Evidence:</b> 5 (Therapeutic).</p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag027"},"PeriodicalIF":1.9,"publicationDate":"2026-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147505568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Serially Stacked Acellular Dermal Matrices in 2-Stage Implant-Based Breast Reconstruction.","authors":"Jina Yom, Isabelle T Smith, Gabrielle P Odoom, Neil Tanna","doi":"10.1093/asjof/ojag024","DOIUrl":"https://doi.org/10.1093/asjof/ojag024","url":null,"abstract":"<p><p>Acellular dermal matrix (ADM) is widely used in implant-based breast reconstruction for implant stabilization, soft-tissue augmentation, and reduced capsular contracture, although its use in this setting remains off-label. Conventional approaches involve placing a single ADM layer during first-stage tissue expander placement. The authors present a novel approach that utilizes ADM in both stages of tissue expander/implant-based breast reconstruction, creating a bilayer ADM construct to enhance soft tissue support. This study aimed to describe the technique of serially stacked ADM in implant-based breast reconstruction and assess its preliminary safety profile. A retrospective review was conducted of all patients who received bilayer ADM in expander/implant-based breast reconstruction by a single surgeon between July 2020 and May 2024. Patient demographics, operative details, time between stages, follow-up duration, and major complications were assessed. Nineteen patients were included in this study. The mean age was 46 ± 8.6 years, and the mean BMI was 21.6 ± 2.85 kg/m². Two patients had a history of radiation therapy. Seventeen reconstructions were prepectoral, and 2 were subpectoral. The average time from expander placement to implant exchange was 180 days. The average follow-up after the second stage was 10.8 months. No patients required reoperation or hospital readmission after either stage, and no major intraoperative or postoperative complications were reported. Preliminary findings from this cohort suggest that stacked ADM may be considered a safe and effective adjunct for enhancing soft tissue coverage in implant-based breast reconstruction. Larger prospective studies are needed to confirm these early results. <b>Level of Evidence</b>: 4 (Therapeutic).</p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag024"},"PeriodicalIF":1.9,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12989474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response by Hadid et al to \"Hemostatic Nets in Facelifts: A Systematic Review and Meta-Analysis of Postoperative Complications and Patient Outcomes\" by Caimi et al.","authors":"Karam Hadid, Forrest Bohler, Kongkrit Chaiyasate","doi":"10.1093/asjof/ojaf146","DOIUrl":"https://doi.org/10.1093/asjof/ojaf146","url":null,"abstract":"","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojaf146"},"PeriodicalIF":1.9,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12907025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146215062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Carboxytherapy for Genitourinary Syndrome of Menopause: A Pilot Study.","authors":"Antonella De Ponte, Sara Sofía Bermúdez Sparice, Luciana Bergamaschi, Sonia Baulies, Sandra Garcia, Ignacio Rodríguez, Silvia Cabrera","doi":"10.1093/asjof/ojag019","DOIUrl":"https://doi.org/10.1093/asjof/ojag019","url":null,"abstract":"<p><p>Carboxytherapy has emerged as a promising nonhormonal therapy for genitourinary syndrome of menopause (GSM) and associated female sexual dysfunction. GSM, characterized by vulvovaginal tissue changes because of estrogen depletion, often leads to vaginal dryness, reduced elasticity, and dyspareunia. This pilot study aimed to evaluate the preliminary efficacy and safety of carboxytherapy in postmenopausal women with GSM. In this prospective pilot trial, postmenopausal women with GSM underwent 5 sessions of controlled CO₂ administration using a specialized carboxytherapy device. Outcomes were assessed using the Bachmann Vaginal Health Index (VHI), the Vulvar Health Index (VuHI), the Female Sexual Function Index-6 (FSFI-6), and pain measured with the visual analog scale (VAS). Evaluations were performed at baseline and 1 month after treatment. Nineteen women completed the study. Posttreatment assessments demonstrated significant improvements in VHI scores (from 12.55 ± 2.56 to 18.26 ± 3.72; <i>P</i> < .001) and decreases in VuHI scores (from 9.80 ± 2.40 to 3.37 ± 3.67; <i>P</i> < .001). FSFI-6 scores improved from 12.55 ± 4.70 to 17.95 ± 7.61 (<i>P</i> = .017). Pain during treatment was minimal, with a mean VAS score of 1.95 ± 0.94. Carboxytherapy appears to be a safe, well-tolerated, and potentially effective nonhormonal option for managing GSM, particularly in cases with significant vulvar involvement. However, given the small sample size, lack of a control group, and short follow-up, these findings should be considered preliminary. Larger randomized controlled trials with longer follow-up are needed to confirm the durability and generalizability of these results. <b>Level of Evidence</b>: 4 (Therapeutic).</p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag019"},"PeriodicalIF":1.9,"publicationDate":"2026-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13098190/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147790468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Use of VISIA-CR Generation 5 in Aesthetic Skin Assessment: A Single-Case Review.","authors":"Carolyn Kim, Bhavana Thota, Jennifer Barillas, John E Hoopman, Jeffrey M Kenkel","doi":"10.1093/asjof/ojag034","DOIUrl":"10.1093/asjof/ojag034","url":null,"abstract":"<p><p>Traditional evaluations of nonsurgical aesthetic treatments often rely on clinical photography and patient-reported outcomes, which are subjective and may overlook subtle or subsurface changes. Advanced imaging technologies, such as the VISIA-CR system, have increased objectivity; however, earlier generations provided limited parameters and lacked integrated analytics. The aim of this review was to illustrate the enhanced capabilities of the VISIA-CR Generation 5 system (VISIA-CR 5) and explore its clinical relevance through a single-case example. A 49-year-old female with Fitzpatrick skin phototype III underwent a combined treatment with intense pulsed light, a fractionated 1927 nm laser, and a dual-wavelength 1470/2940 nm laser. Standardized VISIA-CR 5 imaging was performed at baseline and 3 months. The system captured multispectral images and quantified 8 skin features (visible spots, brown spots, red spots, ultraviolet (UV) spots, texture, pores, porphyrins, and wrinkles) using expanded multiparameter analytics. The VISIA-CR 5 provided multidimensional assessment beyond conventional visual evaluation by quantifying feature intensity, background skin tone, and relative contrast. Although the mean intensity of visible, brown, and UV spots appeared darker at 3 months, contrast-based analysis indicated improved skin tone uniformity. The system also detected reduced fractional area alongside increased count for visible and UV spots, suggesting fragmentation of larger spots rather than proliferation, a level of detail unattainable with traditional methods. This case demonstrates that the VISIA-CR 5 can provide detailed imaging and integrated analytics that support comprehensive, objective evaluation of aesthetic treatment outcomes. Its expanded parameters facilitate detection of subtle, clinically relevant changes and highlight its potential utility in clinical research and practice. <b>Level of Evidence:</b> 4 (Therapeutic).</p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag034"},"PeriodicalIF":1.9,"publicationDate":"2026-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13006135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147505580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Head-to-Head Meta-Analysis of 35,052 Smooth vs Textured Implants in Breast Reconstruction and Augmentation.","authors":"Yousef Tanas, Shadi Tanas, Julie Tanas, Liam Cato, Philong Nguyen, Joshua Wang, Hossam Ghorab, Sarya Swed, Aldona Spiegel","doi":"10.1093/asjof/ojag032","DOIUrl":"https://doi.org/10.1093/asjof/ojag032","url":null,"abstract":"<p><strong>Background: </strong>Whether texturing confers clinical advantages over smooth breast implants remains questionable, especially in the wake of breast implant-associated anaplastic large-cell lymphoma concerns with textured implants.</p><p><strong>Objectives: </strong>The aim of this study was to compare complications, implant-specific events, and patient-reported outcomes between smooth and textured implants across augmentation and reconstruction.</p><p><strong>Methods: </strong>Following PRISMA 2020, the authors synthesized head-to-head comparative studies through January 15, 2025. Random-effects models estimated risk ratios (RRs) for dichotomous outcomes and mean differences for BREAST-Q domains; heterogeneity (<i>I</i> ²) guided prespecified subgroup and sensitivity analyses (eg, implant plane and exclusion of overlapping or historical cohorts). Review Manager v5.4 was used for statistical analysis.</p><p><strong>Results: </strong>Thirty-three studies comprising 35,052 implants met inclusion criteria. In the initial pooled analysis, smooth implants showed higher capsular contracture (RR = 1.69, 95% CI, 1.36-2.11, <i>P</i> < .00001; with significant heterogeneity, <i>I</i> ² = 79%, <i>P</i> < .00001); nonetheless, after stratifying by plane (subpectoral and prepectoral) and conducting sensitivity analyses that excluded overlapping/historical cohorts, the difference was no longer statistically significant (RR = 1.13, 95% CI, 0.82-1.56, <i>P</i> = .46) with no subgroup differences (<i>I</i> ² = 0%, <i>P</i> = .92). Infection was lower with smooth implants (RR = 0.51, 95% CI, 0.30-0.89, <i>P</i> = .02). No differences were detected for seroma, hematoma, rippling, rupture, malposition/rotation, explantation, or BREAST-Q domains.</p><p><strong>Conclusions: </strong>In contemporary, plane-matched comparisons with appropriate sensitivity analyses, smooth implants did not demonstrate a higher capsular contracture risk and were associated with lower infection risk compared with textured implants. Other complications and patient-reported outcomes were similar among both groups.</p><p><strong>Level of evidence 3 therapeutic: </strong></p>","PeriodicalId":72118,"journal":{"name":"Aesthetic surgery journal. Open forum","volume":"8 ","pages":"ojag032"},"PeriodicalIF":1.9,"publicationDate":"2026-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12997531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147488701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}